Trial intelligence / Profile preview

Dexmedetomidine for reducing discharge time in lumbar fusion

NCT00808665Phase 4Completed

Sponsor
Vanderbilt University Medical Center
Start
Jun 2009
Primary completion
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine in spinal stenosis, intervertebral disc disease (IDD), Spinal disease, sponsored by Vanderbilt University Medical Center. Started Jun 2009; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

spinal stenosisintervertebral disc disease (IDD)Spinal disease

Beyond the preview

Go deeper on NCT00808665.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00808665.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call